Cover Image
市場調查報告書

全球分子生物感應器市場:各用途,技術,類型,地區 - 成長,趨勢,預測(2018年∼2023年)

Global Molecular Biosensors Market - Segmented by Application, Technology, Type, and Geography - Growth, Trends, and Forecast (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 391373
出版日期 內容資訊 英文 110 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球分子生物感應器市場:各用途,技術,類型,地區 - 成長,趨勢,預測(2018年∼2023年) Global Molecular Biosensors Market - Segmented by Application, Technology, Type, and Geography - Growth, Trends, and Forecast (2018 - 2023)
出版日期: 2018年03月01日 內容資訊: 英文 110 Pages
簡介

全球分子生物感應器市場,預計從2018年到2023年,以7.5%的年複合成長率發展。各地區中,以奈米技術領域的分子生物感應器的用途擴大為背景,北美成為最大市場。

本報告提供全球分子生物感應器市場調查,市場概要,各用途、技術、類型、地區的市場規模的變化與預測,市場趨勢,成長要素、阻礙因素以及市場機會、課題分析,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 成長要素,阻礙因素,機會,課題分析

  • 市場成長要素
    • 慢性疾病及文明病的盛行率的上升
    • POC檢驗的需求增加
    • 各種產業上生物感應器的應用擴大
  • 市場阻礙因素
    • 生物感應器的嚴格法規必要條件
    • 償付制度的問題
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各用途
    • 醫療診斷
    • 製藥、生物製藥
    • 食品、飲料
    • 環境安全
    • 防衛、安全
    • 其他
  • 各技術
    • 電化學生物感應器
    • 光學生物感應器
    • 熱生物感應器
    • 壓電生物感應器
  • 各類型
    • 生物訊號傳達
    • 傳達要素
    • 認識要素
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • 合併及收購分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要業者

  • Abbott Laboratories Inc.
  • Bayer AG
  • F. Hoffmann La Roche
  • Johnson and Johnson
  • LifeSensors Inc.
  • Medtronic Inc.
  • Nova biomedical Corporation
  • Siemens Healthcare

第10章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 48746

The molecular biosensors market is expected to register a CAGR of 7.5% during 2018 to 2023 (the forecast period). North America dominates the market, due to increasing application of molecular biosensors in nanotechnology.

Increasing Demand for Point of Care Testing

Point of care (POC) testing involves the performing a diagnostic test of a laboratory, which produces rapid and reliable result, aiding in identifying or managing chronic disease and acute infections. More than two-third of Americans have smartphones, and thus, apps and wearable are increasingly used by people seeking to monitor heart rate and sleep patterns. These POC devices use biosensors that can potentially improve patient care through real-time and remote health monitoring. Thus, increasing demand of POC testing is driving the growth of the molecular biosensors market.

Strict Regulatory Requirements for Biosensors

Since numerous design variations of biosensors for IVD were developed in recent years, in some cases, it is still left to the manufacturer to determine the best methods to attain quality objectives. However, it is mandatory that the key quality system requirements are met or exceeded to enable development of a safe and effective diagnostics device. Thus, these strict regulatory requirements for biosensors are hindering the growth of the molecular biosensors market.

Additionally, reimbursement policies issues in healthcare systems are also hindering the growth of the molecular biosensors market.

North America to Dominate the Market

North America has the largest market share due to rise in chronic diseases, such as diabetes and heart disease, and thus, patients are adopting technologically advanced products for early diagnosis. Additionally, increasing point of care testing in the United States is also favoring the growth of the molecular biosensors market.

Key Developments in the Market

January 2018 - Scientist developed an ultra-thin, flexible biosensor for real-time glucose tracking, which can be incorporated into the watch or contact lenses.

Major Players - Siemens Healthcare, LifeSensors Inc., Nova biomedical Corporation, Abbott Laboratories Inc., Johnson and Johnson, Medtronic Inc., F. Hoffmann La Roche, and Bayer AG, among others.

Reasons to Purchase This Report

Market analysis for the molecular biosensors market, with region-specific assessments and competition analysis on a global and regional scale

Analyzing various perspectives of the industry with the help of Porter's five forces analysis

The treatment type that is expected to dominate the market

Regions that are expected to witness the fastest growth during the forecast period

Identify the latest developments, market shares, and strategies employed by the major market players

3 months analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Product and Services
    • 5.2.5 Competitive Rivalry Within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1 Market Driver
    • 6.1.1 Increasing Prevalence of Chronic and Lifestyle Induced Diseases
    • 6.1.2 Increasing Demand for Point of Care Testing
    • 6.1.3 Increasing Application of Biosensors in Various Industries
  • 6.2 Market Restraint
    • 6.2.1 Strict Regulatory Requirements for Biosensors
    • 6.2.2 Reimbursement Policies Issues in Healthcare Systems
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 By Application
    • 7.1.1 Medical Diagnostics
    • 7.1.2 Pharma & Biotech
    • 7.1.3 Food and Beverages
    • 7.1.4 Environment Safety
    • 7.1.5 Defense and Security
    • 7.1.6 Others
  • 7.2 By Technology
    • 7.2.1 Electrochemical Biosensors
    • 7.2.2 Optical Biosensors
    • 7.2.3 Thermal Biosensors
    • 7.2.4 Piezoelectric Biosensors
  • 7.3 By Type
    • 7.3.1 Biological Signaling
    • 7.3.2 Transduction Element
    • 7.3.3 Recognition Element
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States
      • 7.4.1.2 Canada
      • 7.4.1.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 France
      • 7.4.2.2 Germany
      • 7.4.2.3 United Kingdom
      • 7.4.2.4 Italy
      • 7.4.2.5 Spain
      • 7.4.2.6 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China
      • 7.4.3.2 Japan
      • 7.4.3.3 India
      • 7.4.3.4 Australia & New Zealand
      • 7.4.3.5 South Korea
      • 7.4.3.6 Rest of Asia-Pacific
    • 7.4.4 Middle East & Africa
      • 7.4.4.1 GCC
      • 7.4.4.2 South Africa
      • 7.4.4.3 Rest of Middle East & Africa
    • 7.4.5 South America
      • 7.4.5.1 Brazil
      • 7.4.5.2 Argentina
      • 7.4.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers and Acquisition Analysis
  • 8.2 Agreements, Collaborations & Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 Abbott Laboratories Inc.
  • 9.2 Bayer AG
  • 9.3 F. Hoffmann La Roche
  • 9.4 Johnson and Johnson
  • 9.5 LifeSensors Inc.
  • 9.6 Medtronic Inc.
  • 9.7 Nova biomedical Corporation
  • 9.8 Siemens Healthcare

List Not Exhaustive

10. Future of the Market

Back to Top